Transcenta Holding Limited is a clinical stage biotherapeutics company with fully-integrated capabilities in research, development, regulatory and manufacturing of biologics. With five global sites, Discovery Research, Translational Research and Clinical Development Center in Suzhou, Process and Product Development Center and a next-Generation Manufacturing Facility in Hangzhou, and additional Clinical Development Centers in Shanghai, Beijing and Boston, US, Transcenta has over 10 innovative pipeline molecules in development in oncology and select non-oncology areas. Transcenta's mission is to deliver high quality innovative biologics at affordable price to patients around the world.